EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hydroxyapatite-Based Alendronate Coatings for Local Drug Delivery and Implant Osseointegration

Niculescu Bogdan, Dirnu Rodica, Cristian Cosmin Arsenie, Pirscoveanu Denisa Floriana Vasilica, Diana-Maria Trasca, Adina Maria Kamal, Renata Maria Varut, Pluta Ion Dorin, Maria Stoica

Pharmaceutics · 08.11.2026 · 18 (11) · 1447

DOI: 10.3390/pharmaceutics18111447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 08.11.2026. Verfasst von Niculescu Bogdan und 8 weiteren Autor:innen. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Hydroxyapatite (HA) coatings offer an osteoconductive interface and a mineral reservoir for alendronate. Their pharmaceutical value depends on whether binding produces biologically available exposure without impairing healing. This review examines that relationship in HA–alendronate coatings on titanium.

Methods

A structured critical narrative review used PubMed/MEDLINE, Scopus and Web of Science Core Collection, with reference-list screening. Screening identified 62 primary studies; contextual literature supported mechanistic and translational interpretation.

Results

Adsorption, mineral incorporation, laser deposition and hybrid reservoirs produce different loading and release profiles. Cell and animal findings depend on formulation, dose, comparator and model. Mineral content, bone-to-implant contact and mechanical fixation provide complementary evidence and are not interchangeable outcomes. Human studies have mainly evaluated other bisphosphonates in fibrinogen coatings or alendronate applied as a gel around dental implants. Some reported less marginal bone loss, but improvements in implant stability were inconsistent. These results do not directly establish the efficacy of HA–alendronate coatings.

Conclusions

Translation requires reproducible manufacture, measured active-drug availability, preserved physiological remodeling, durable coating adhesion and controlled trials for a defined implant indication. Strong mineral binding alone does not establish effective local therapy.

Förderung

  • University of Medicine and Pharmacy of Craiova

Zitieren

APA

Bogdan, N., Rodica, D., Arsenie, C. C., Vasilica, P. D. F., Trasca, D., Kamal, A. M., Varut, R. M., Dorin, P. I., & Stoica, M. (2026). Hydroxyapatite-Based Alendronate Coatings for Local Drug Delivery and Implant Osseointegration. Pharmaceutics, 18(11), 1447. https://doi.org/10.3390/pharmaceutics18111447

Vancouver

Bogdan N, Rodica D, Arsenie CC, Vasilica PDF, Trasca D, Kamal AM, et al. Hydroxyapatite-Based Alendronate Coatings for Local Drug Delivery and Implant Osseointegration. Pharmaceutics. 2026;18(11):1447. doi:10.3390/pharmaceutics18111447

BibTeX
@article{Bogdan2026,
  author = {Bogdan, Niculescu and Rodica, Dirnu and Arsenie, Cristian Cosmin and Vasilica, Pirscoveanu Denisa Floriana and Trasca, Diana-Maria and Kamal, Adina Maria and Varut, Renata Maria and Dorin, Pluta Ion and Stoica, Maria},
  title = {Hydroxyapatite-Based Alendronate Coatings for Local Drug Delivery and Implant Osseointegration},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1447},
  doi = {10.3390/pharmaceutics18111447}
}
Kostenlos starten →